Work

Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer

Year: 2024

Type: article

Source: Journal of Gastrointestinal Cancer

DOI: 10.1007/s12029-024-01106-7

Authors: Munenobu Kashiwa, Hiroyuki Maeda

Institutions: Kanazawa University, Ritsumeikan University

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Japan Society for the Promotion of Science

Award: Health Economic Evaluation Research for Optimizing Anticancer Drug Selection in Advanced Gastric Cancer

OpenAlex ID: W4401794241

FWCI: 1.674

Cites: 26

Cited by: 4

Related to: 10